3[1]International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease[J]. Lancet, 1990, 335(8697): 1078-1080.
4[2]Krause Ⅰ, Molad Y, Mitrani M, et al. Pathergy reaction in Behcet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression[J]. Clin Exp Rheumatol, 2000, 18(1): 71-74.
5Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet' s disease. Int Rev Immunol, 1997,14:21
6Direskeneli H, Eksioglu-Demiralp E, Yavuz S, et al. T cell responses to 60/65KD heat shock protein derived peptides in Turkish patients with Behcct' s disease. The Joumal of Rheumatology, 2000,27(3):708
7Zouboulis CC, Drtanous CE. Treatment of Adamantiades-Behcet's disease with systemic interferon alfa. Arch Dermatol,1998,134:1010
8Miyachi Y, Taniguchi S, Ozaki M, et al. Colchicine in the treatment of the cutaneous manifectations of Behcet's disease. Br J Dermatol,1981,104:67
9Hamuryudan V, Mat C, Saip S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's syndrome a randomized deuble-blind, placebo-controlled trial. Ann Intern Med,1998,128:443
